Understand The Current Buy Rationale for Salesforce
Salesforce just posted a quarter that silenced its loudest critics, but the investment case for buying at current prices is more complicated than the 22% weekly rally suggests.
At $256, Salesforce (NYSE:CRM | CRM Price Prediction) warrants a closer look from long-term investors. The stock rallied 22.39% in a week on a Q2 print that validated the Agentforce thesis.
Salesforce is the largest enterprise SaaS CRM vendor, repositioning itself as the “Agentic Enterprise” platform by layering Agentforce AI agents, Data 360, Slack, MuleSoft, Tableau, and newly acquired Informatica atop its system-of-record data. The stock spent most of 2026 in a drawdown as investors debated whether AI would erode seat-based revenue. The FY27 Q2 report shifted that conversation.
Revenue of $11.345 billion grew 10.83%, Agentforce ARR crossed $1.5 billion, and guidance moved higher. The debate now centers on durability of that reacceleration.
Agentic Platform Reprices the Stock
Agentforce and Data 360 combined ARR reached nearly $3.9 billion, up over 210% year over year, with Agentic Work Units growing 97% quarter over quarter. Management raised FY27 revenue guidance to $46.1 billion to $46.4 billion with non-GAAP operating margin at 34.3%.
Valuation looks reasonable relative to that growth. Shares trade at roughly 19 times forward earnings against FY27 EPS guidance of $16.67 to $16.71 and implied re-acceleration into FY28. Free cash flow of $1.098 billion grew 81.49%, and the $25 billion accelerated share repurchase cut diluted share count to 821 million from 962 million a year ago.
Fall catalysts include Investor Day on September 16, 2026 at Dreamforce, the ClaudeForce general availability launch, and closings of Contentful and Fin. The analyst community is aligned, with 73% bullish, 24% neutral, and 4% bearish readings on file.
Why the Rally Could Fade
GAAP EPS of $4.29 included a $2.43 per share gain on strategic investments (largely Anthropic), and the non-GAAP $5.90 included $2.53 per share from the same source. Strip that out and the underlying beat shrinks significantly.
Operating income was effectively flat year over year, restructuring charges jumped to $94 million, and management still says it is “too soon to call” a durable marketing-cloud recovery. Consumption pricing is early, license revenue is volatile, and Informatica integration carries real risk.
Shares have rallied to the $267.75 52-week high area, and the $262.54 average analyst target now sits below current price. Two analysts carry Strong Sell ratings.
Case for Waiting
A 35.9% one-month move ahead of Investor Day is substantial to chase. Payoff on consumption monetization will take multiple quarters to appear in reported growth. Investors who missed the print may reasonably wait for a pullback toward the $200 200-day moving average or for FY28 guidance clarity.
Key catalysts: Agentforce ARR pushing through $2.5 billion, cRPO growth accelerating above 15%, or premium-edition attach rates disclosed at Dreamforce.
By the Numbers
Salesforce trades at $256 with an average analyst price target of $262.54, implying roughly 3% upside from 55 covering analysts, with 5 Strong Buy, 35 Buy, 13 Hold, 0 Sell, and 2 Strong Sell ratings. The stock trades at 23 times trailing earnings and 19 times forward, against expected FY27 revenue growth of 11% to 12%.
Year to date, CRM is down 2.86%, while the S&P 500 has returned 12.82%. Over one year, CRM is up 1.44% versus 18.56% for the index. The gap reflects the bull case: earnings power has stopped deteriorating.
Why Salesforce Looks Compelling at $256
Appreciation hinges on a durable rerating as consumption-based ARR compounds. Salesforce controls the customer, product, and workflow data that enterprise AI agents need to function, and customers are paying more as agents deploy. 50% of Agentforce bookings came from customers refilling credits, and durable seat growth in Sales and Service refutes the seat-degradation narrative that compressed multiples through H1 2026.
At roughly 19 times forward earnings for a company guiding to 34.3% non-GAAP operating margins, growing free cash flow, and shrinking share count, the market still discounts execution risk. The consumption-based upside is not yet in the model, anchors a credible long-duration path.
Timeline is 12 to 24 months. Watch Agentforce ARR crossing $4 billion, cRPO growth staying above 14% in constant currency, and premium-edition attach on ClaudeForce and Headless Salesforce. The thesis breaks if operating margin guidance retreats or Agentforce growth stalls before consumption pricing scales.
Salesforce is the rare mega-cap where the AI story is finally showing in the ARR line, and the market has not fully repriced for it.
Contact [email protected] for any questions or corrections.
Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.
Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.
At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.
